Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CPI1189 (REN-1189) is a TNF-a release inhibitor potentially for the treatment of sciatica and postherpetic neuralgia.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 55.00 | |
10 mg | In stock | $ 84.00 | |
25 mg | In stock | $ 172.00 | |
50 mg | In stock | $ 289.00 | |
100 mg | In stock | $ 463.00 | |
500 mg | In stock | $ 987.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 61.00 |
Description | CPI1189 (REN-1189) is a TNF-a release inhibitor potentially for the treatment of sciatica and postherpetic neuralgia. |
Synonyms | CPI-1189, REN-1189, CPI 1189 |
Molecular Weight | 234.29 |
Formula | C13H18N2O2 |
CAS No. | 183619-38-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (213.4 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CPI1189 183619-38-7 Apoptosis TNF Inhibitor Tumor Necrosis Factor Receptor inhibit TNF Receptor TNFR REN 1189 CPI-1189 REN1189 REN-1189 CPI 1189 inhibitor